Mortality due to immunotherapy related hepatitis

Prachi Bhave; Andrew Buckle; Shahneen Sandhu; Siddharth Sood

doi:10.1016/j.jhep.2018.06.012

Related publications

Article2025

Global paid and unpaid productivity losses due to cancer-related mortality

Yek‐Ching Kong, Jean Niyigaba, Phuong Bich Tran, Jérôme Vignat, Freddie Ian Bray, Cindy L. Gauvreau, Paul Hanly, Alison Pearce, Marianna de Camargo Cancela, Marta Ortega‐Ortega, Nirmala Bhoo‐Pathy, André Ilbawi, Filip Meheus, Isabelle Soerjomataram

Article2002

Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System

Stefania Bonaccorso, Valentina Marino, Antonella Puzella, Massimo Pasquini, Massimo Biondi, Marco Artini, C. Almerighi, Robert Verkerk, Herbert Y. Meltzer, Michael Maes

Article2019

Autoimmune hepatitis and IgG4-related disease

Kosuke Minaga, Tomohiro Watanabe, Hobyung Chung, Masatoshi Kudo

Article2007

The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection

Hermann E. Wasmuth, Mirko Moreno Zaldivar, Marie‐Luise Berres, Alexa Werth, David Scholten, Sonja Hillebrandt, Frank Tacke, P Schmitz, Edgar Dahl, T. Wiederholt, Claus Hellerbrand, Thomas Berg, Ralf Weiskirchen, Christian Trautwein, Frank Lammert

Article2021

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?

Masatoshi Kudo